TransMedics Group (NASDAQ: TMDX)
TransMedics Group Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
TransMedics Group Company Info
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
News & Analysis
Is TransMedics Stock a Buy Before 2025?
Down Over 60%, Is TransMedics Stock a Buy on the Dip?
3 Cheap Stock to Buy Now
Three stocks poised for upside, both near-term and long-term.
Why TransMedics Stock Plummeted Today
1 Top Growth Stock Down 56% to Buy After Its Recent Pullback
This growth stock has been on my watchlist for a while and might soon be included in my portfolio.
2 Hypergrowth Stocks That Are Screaming Buys in November
Is TransMedics Group Stock a Buy?
This organ transplant specialist is down, but still has plenty of signs of life.
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of transplant organ delivery services.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.